
Industry, Aerospace
AMable
AMable provides support for SMEs and mid-cap companies to adopt additive manufacturing solutions.
Biogenic Organotropic Wetsuits: self-contained implantable materials and devices
Project dates
2020 - 2024
Website
Role of Zabala
partner
Project led by
CSGI - Consorzio per lo Sviluppo dei sistemi a Grande Interfase
11
Partners
7
Countries
4.5
M€ budget
4
Years
The objective of the project is to explore and consolidate a technology capable of endowing the capabilities of extracellular vesicles (EVs) to superparamagnetic nanodevices by “dressing” them with a “suit” of one or more layers of EV membrane “fabric.”
Until a few years ago, cell communication was thought to be regulated exclusively through cell-cell junctions or by the exchange of soluble molecular factors. However, it has been discovered that membranous nanoparticles, called extracellular nanovesicles (EVs), and tunneling nanotubes are also intercellular communication agents “made by cells for cells.” Their function is to transport lipids, proteins and nucleic acids, and they stand out for their precision and targeting ability, carried out thanks to the unique composition and structure of their membrane (which to date is inaccessible to synthetic mimics).
The BOW project will develop a technology capable of endowing the capabilities of extracellular vesicles (EVs) to superparamagnetic nanodevices (Magnetic Bead Devices, MBDs) by “dressing” them with a “suit” of one or several layers of EV membrane “fabric.” It will establish a general and viable paradigm for applying key biomimetic functions – including the ability to evade the immune system and reach target organs/tissues/tumors – to any synthetic nanodevice. In turn, it will be disruptive in that it will be the first example of biogenic nanotechnology.
This technology will promote the progress of implantable nanodevices and nanomaterials towards sustainable production and the clinic, impacting people’s quality of life. The main objectives include: i) production of EVs with biomimetic and organotropic functions, ii) synthesis and functionalisation of MBDs, iii) engineering of a microfluidic device for optimised fabrication of membrane-coated MBD EVs, iv) evaluation of biological performance and nanotoxicity of evMBDs and in-vitro, ex-vivo and in-vivo.
This project has received funding from the European Union’s FET Proactive programme, under grant agreement No. 952183.
“The BOW project will develop and demonstrate an innovative technology based on extracellular vesicles and paragenetic nanodevices with applications in various fields related to human health (clinical, environmental and food safety). BOW is a clear example of science at the service of society.”
Aránzazu Albístur
Kaila platform Manager
Industry, Aerospace
AMable provides support for SMEs and mid-cap companies to adopt additive manufacturing solutions.
Industry, Aerospace
The aim of the FETFX project is to promote FET research among a wide range of actors through community building...
Health, Agri-food and Bioeconomy
The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of two new clinical trials against...
News
EUHubs4Data
Opinion
SINFONIA
Leire Martiarena
Social Innovation Knowledge Area Leader
Publication
Regions
Innovation is key to making regions more digital and sustainable, and in our publication you will learn about the funding opportunities that make this possible
The important thing is not to keep moving, but rather to know in which direction to go. Our 37% success rate proves that we know how to guide our clients.
Our compass is our clients; our mission is to solve their problems, guiding them so that innovation becomes their key to competitiveness.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
Please enable Strictly Necessary Cookies first so that we can save your preferences!